Cargando…
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
Despite all the important advances in its diagnosis and treatment, acute myocardial infarction (AMI) is still one of the most prominent causes of morbidity and mortality worldwide. Early identification of patients at high risk of poor outcomes through the measurement of various biomarker concentrati...
Autores principales: | Stătescu, Cristian, Anghel, Larisa, Tudurachi, Bogdan-Sorin, Leonte, Andreea, Benchea, Laura-Cătălina, Sascău, Radu-Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409468/ https://www.ncbi.nlm.nih.gov/pubmed/36012430 http://dx.doi.org/10.3390/ijms23169168 |
Ejemplares similares
-
A Systematic Review on the Risk Modulators of Myocardial Infarction in the “Young”—Implications of Lipoprotein (a)
por: Stătescu, Cristian, et al.
Publicado: (2023) -
Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023) -
The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19
por: Anghel, Larisa, et al.
Publicado: (2022) -
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023) -
From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis
por: Anghel, Larisa, et al.
Publicado: (2020)